Transcriptome of blood cells as a reservoir of cardiovascular biomarkers

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1864, Issue 1, 2017, Pages 209-216

  Devaux, Yvan ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Biomarker; Cardiovascular disease; Noncoding RNA; Personalized medicine; RNA; Transcriptomics

Indexed keywords

BIOLOGICAL MARKER; CIRCULAR RNA; LONG UNTRANSLATED RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG; UNTRANSLATED RNA; MESSENGER RNA; PLASMA PROTEIN;

BLOOD CELL; CARDIOVASCULAR DISEASE; DISEASE COURSE; GENE EXPRESSION PROFILING; GENETIC CODE; HUMAN; NONHUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; BLOOD; CARDIOMEGALY; CARDIOVASCULAR SYSTEM; CHEMISTRY; CLASSIFICATION; HEART FAILURE; METABOLISM; PATHOLOGY;

BIOMARKERS; BLOOD CELLS; BLOOD PROTEINS; CARDIOMEGALY; CARDIOVASCULAR SYSTEM; HEART FAILURE; HUMANS; PRECISION MEDICINE; RNA, MESSENGER; RNA, UNTRANSLATED; TRANSCRIPTOME;

EID: 84995812347     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2016.11.005     Document Type: Review

References (69)

1. [1] Nichols, M., Townsend, N., Scarborough, P., Rayner, M., Cardiovascular disease in Europe 2014: epidemiological update. Eur. Heart J., 35, 2014, 2929.
2. [2] Murray, C.J.L., Barber, R.M., Foreman, K.J., et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386 (2015), 2145–2191.
3. [3] Azuaje, F.J., Dewey, F.E., Brutsaert, D.L., Devaux, Y., Ashley, E.A., Wagner, D.R., Systems-based approaches to cardiovascular biomarker discovery. Circ. Cardiovasc. Genet. 5 (2012), 360–367.
4. [4] Creemers, E.E., Tijsen, A.J., Pinto, Y.M., Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?. Circ. Res. 110 (2012), 483–495.
5. [5] Goretti, E., Wagner, D.R., Devaux, Y., miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine?. Trends Mol. Med. 20 (2014), 716–725.
6. [6] Consortium, E.P., Dunham, I., Kundaje, A., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489 (2012), 57–74.
7. [7] Comings, D.E., The structure and function of chromatin. Adv. Hum. Genet. 3 (1972), 237–431.
8. [8] Devaux, Y., Zangrando, J., Schroen, B., et al. Long noncoding RNAs in cardiac development and ageing. Nat. Rev. Cardiol. 12 (2015), 415–425.
9. [9] Thum, T., Condorelli, G., Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ. Res. 116 (2015), 751–762.
10. [10] Boon, R.A., Jaé, N., Holdt, L., Dimmeler, S., Long noncoding RNAs from clinical genetics to therapeutic targets?. J. Am. Coll. Cardiol. 67 (2016), 1214–1226.
11. [11] Hansen, T.B., Veno, M.T., Jensen, T.I., Schaefer, A., Damgaard, C.K., Kjems, J., Argonaute-associated short introns are a novel class of gene regulators. Nat. Commun., 7, 2016, 11538.
12. [12] Ounzain, S., Micheletti, R., Beckmann, T., et al. Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs. Eur. Heart J. 36 (2015), 353–368.
13. [13] Zangrando, J., Zhang, L., Vausort, M., Maskali, F., Marie, P.Y., Wagner, D.R., Devaux, Y., Identification of candidate long non-coding RNAs in response to myocardial infarction. BMC Genomics, 15, 2014, 460.
14. [14] Kumarswamy, R., Bauters, C., Volkmann, I., et al. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ. Res. 114 (2014), 1569–1575.
15. [15] Vausort, M., Wagner, D.R., Devaux, Y., Long noncoding RNAs in patients with acute myocardial infarction. Circ. Res. 115 (2014), 668–677.
16. [16] Azuaje, F., Devaux, Y., Wagner, D., Computational biology for cardiovascular biomarker discovery. Brief. Bioinform. 10 (2009), 367–377.
17. [17] Azuaje, F., Devaux, Y., Wagner, D.R., Coordinated modular functionality and prognostic potential of a heart failure biomarker-driven interaction network. BMC Syst. Biol., 4, 2010, 60.
18. [18] Romanoski, C.E., Che, N., Yin, F., et al. Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1. Circ. Res. 109 (2011), e27–e41.
19. [19] Dewey, F.E., Perez, M.V., Wheeler, M.T., et al. Gene coexpression network topology of cardiac development, hypertrophy, and failure. Circ. Cardiovasc. Genet. 4 (2011), 26–35.
20. [20] Lin, C.C., Hsiang, J.T., Wu, C.Y., Oyang, Y.J., Juan, H.F., Huang, H.C., Dynamic functional modules in co-expressed protein interaction networks of dilated cardiomyopathy. BMC Syst. Biol., 4, 2010, 138.
21. [21] Civelek, M., Manduchi, E., Riley, R.J., Stoeckert, C.J. Jr., Davies, P.F., Coronary artery endothelial transcriptome in vivo: identification of endoplasmic reticulum stress and enhanced reactive oxygen species by gene connectivity network analysis. Circ. Cardiovasc. Genet. 4 (2011), 243–252.
22. [22] Huan, T., Zhang, B., Wang, Z., et al. A systems biology framework identifies molecular underpinnings of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 33 (2013), 1427–1434.
23. [23] Valk, P.J., Verhaak, R.G., Beijen, M.A., et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N. Engl. J. Med. 350 (2004), 1617–1628.
24. [24] Bullinger, L., Dohner, K., Bair, E., Frohling, S., Schlenk, R.F., Tibshirani, R., Dohner, H., Pollack, J.R., Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N. Engl. J. Med. 350 (2004), 1605–1616.
25. [25] Zak, D.E., Penn-Nicholson, A., Scriba, T.J., et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet, 2016.
26. [26] Wingrove, J.A., Daniels, S.E., Sehnert, A.J., et al. Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis. Circ. Cardiovasc. Genet. 1 (2008), 31–38.
27. [27] Vargas, J., Lima, J.A.C., Kraus, W.E., Douglas, P.S., Rosenberg, S., Use of the Corus® CAD gene expression test for assessment of obstructive coronary artery disease likelihood in symptomatic non-diabetic patients. PLoS Currents, 5, 2013 (ecurrents.eogt.0f04f6081905998fa6081905992b6099593478aeab).
28. [28] Azuaje, F.J., Rodius, S., Zhang, L., Devaux, Y., Wagner, D.R., Information encoded in a network of inflammation proteins predicts clinical outcome after myocardial infarction. BMC Med. Genet., 4, 2011, 59.
29. [29] Devaux, Y., Bousquenaud, M., Rodius, S., Marie, P.-Y., Maskali, F., Zhang, L., Azuaje, F., Wagner, D., Transforming growth factor beta receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction. BMC Med. Genet., 4, 2011, 83.
30. [30] Devaux, Y., Azuaje, F., Vausort, M., Yvorra, C., Wagner, D.R., Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction. Funct. Integr. Genomics 10 (2010), 329–337.
31. [31] Azuaje, F., Devaux, Y., Vausort, M., Yvorra, C., Wagner, D.R., Transcriptional networks characterize ventricular dysfunction after myocardial infarction: a proof-of-concept investigation. J. Biomed. Inform. 43 (2010), 812–819.
32. [32] Azuaje, F., Devaux, Y., Wagner, D.R., Integrative pathway-centric modeling of ventricular dysfunction after myocardial infarction. PLoS One, 5, 2010, e9661.
33. [33] Rizki, G., Boyer, L.A., Lncing epigenetic control of transcription to cardiovascular development and disease. Circ. Res. 117 (2015), 192–206.
34. [34] Li, D., Chen, G., Yang, J., Fan, X., Gong, Y., Xu, G., Cui, Q., Geng, B., Transcriptome analysis reveals distinct patterns of long noncoding RNAs in heart and plasma of mice with heart failure. PLoS One, 8, 2013, e77938.
35. [35] Yang, Y., Cai, Y., Wu, G., et al. Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease. Clin. Sci. (Lond.) 129 (2015), 675–685.
36. [36] Huang, X., Yuan, T., Tschannen, M., et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics, 14, 2013, 319.
37. [37] Ounzain, S., Pezzuto, I., Micheletti, R., et al. Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease. J. Mol. Cell. Cardiol. 76C (2014), 55–70.
38. [38] Consortium, C.A.D., Deloukas, P., Kanoni, S., et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45 (2013), 25–33.
39. [39] Samani, N.J., Erdmann, J., Hall, A.S., et al. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 357 (2007), 443–453.
40. [40] Korostowski, L., Sedlak, N., Engel, N., The Kcnq1ot1 long non-coding RNA affects chromatin conformation and expression of Kcnq1, but does not regulate its imprinting in the developing heart. PLoS Genet., 8, 2012, e1002956.
41. [41] Bokil, N.J., Baisden, J.M., Radford, D.J., Summers, K.M., Molecular genetics of long QT syndrome. Mol. Genet. Metab. 101 (2010), 1–8.
42. [42] Memczak, S., Jens, M., Elefsinioti, A., et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495 (2013), 333–338.
43. [43] Jeck, W.R., Sharpless, N.E., Detecting and characterizing circular RNAs. Nat. Biotechnol. 32 (2014), 453–461.
44. [44] Jeck, W.R., Sorrentino, J.A., Wang, K., Slevin, M.K., Burd, C.E., Liu, J., Marzluff, W.F., Sharpless, N.E., Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19 (2013), 141–157.
45. [45] Zhang, Y., Zhang, X.O., Chen, T., Xiang, J.F., Yin, Q.F., Xing, Y.H., Zhu, S., Yang, L., Chen, L.L., Circular intronic long noncoding RNAs. Mol. Cell 51 (2013), 792–806.
46. [46] Rybak-Wolf, A., Stottmeister, C., Glazar, P., et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol. Cell 58 (2015), 870–885.
47. [47] Li, Z., Huang, C., Bao, C., et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat. Struct. Mol. Biol. 22 (2015), 256–264.
48. [48] Hansen, T.B., Jensen, T.I., Clausen, B.H., Bramsen, J.B., Finsen, B., Damgaard, C.K., Kjems, J., Natural RNA circles function as efficient microRNA sponges. Nature 495 (2013), 384–388.
49. [49] Wang, K., Long, B., Liu, F., et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur. Heart J., 2016.
50. [50] Militello, G., Weirick, T., John, D., Doring, C., Dimmeler, S., Uchida, S., Screening and validation of lncRNAs and circRNAs as miRNA sponges. Brief. Bioinform., 2016.
51. [51] Burd, C.E., Jeck, W.R., Liu, Y., Sanoff, H.K., Wang, Z., Sharpless, N.E., Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet., 6, 2010, e1001233.
52. [52] Boeckel, J.N., Jae, N., Heumuller, A.W., et al. Identification and characterization of hypoxia-regulated endothelial circular RNA. Circ. Res. 117 (2015), 884–890.
53. [53] Vausort, M., Salgado-Somoza, A., Zhang, L., et al. Myocardial infarction-associated circular RNA predicting left ventricular dysfunction. J. Am. Coll. Cardiol. 68 (2016), 1247–1248.
54. [54] Memczak, S., Papavasileiou, P., Peters, O., Rajewsky, N., Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood. PLoS One, 10, 2015, e0141214.
55. [55] Frieler, R.A., Mortensen, R.M., Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation 131 (2015), 1019–1030.
56. [56] Libby, P., Nahrendorf, M., Swirski, F.K., Leukocytes link local and systemic inflammation in ischemic cardiovascular disease: an expanded “cardiovascular continuum”. J. Am. Coll. Cardiol. 67 (2016), 1091–1103.
57. [57] Barron, H.V., Cannon, C.P., Murphy, S.A., Braunwald, E., Gibson, C.M., Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 102 (2000), 2329–2334.
58. [58] Gerling, I.C., Ahokas, R.A., Kamalov, G., Zhao, W., Bhattacharya, S.K., Sun, Y., Weber, K.T., Gene expression profiles of peripheral blood mononuclear cells reveal transcriptional signatures as novel biomarkers of cardiac remodeling in rats with aldosteronism and hypertensive heart disease. JACC Heart Fail 1 (2013), 469–476.
59. [59] Dutta, P., Nahrendorf, M., Monocytes in myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 1066–1070.
60. [60] Nahrendorf, M., Swirski, F.K., Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction?. Eur. Heart J. 37 (2016), 868–872.
61. [61] Hofmann, U., Frantz, S., Role of T-cells in myocardial infarction. Eur. Heart J. 37 (2016), 873–879.
62. [62] Fertin, M., Dubois, E., Belliard, A., Amouyel, P., Pinet, F., Bauters, C., Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction. Am. J. Cardiol. 110 (2012), 277–283.
63. [63] Vanhoutte, D., Schellings, M., Pinto, Y., Heymans, S., Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc. Res. 69 (2006), 604–613.
64. [64] Kelly, D., Khan, S.Q., Thompson, M., Cockerill, G., Ng, L.L., Samani, N., Squire, I.B., Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction. Eur. Heart J. 29 (2008), 2116–2124.
65. [65] Palmerini, T., Brener, S.J., Genereux, P., et al. Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial). Am. J. Cardiol. 112 (2013), 1860–1866.
66. [66] Vausort, M., Salgado-Somoza, A., Zhang, L., et al. MICRA: myocardial infarction-associated circular RNA predicting left ventricular dysfunction. J. Am. Coll. Cardiol, 2016 (Accepted for publication).
67. [67] Pham, M.X., Teuteberg, J.J., Kfoury, A.G., et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N. Engl. J. Med. 362 (2010), 1890–1900.
68. [68] Crespo-Leiro, M.G., Stypmann, J., Schulz, U., et al. Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II. Eur. Heart J, 2016.
69. [69] Repetto, E., Lichtenstein, L., Hizir, Z., et al. RNY-derived small RNAs as a signature of coronary artery disease. BMC Med., 13, 2015, 259.